Proud to be ATU
ATU Presents 2007 Donations to Multiple Sclerosis Research
The ATU recently presented its 2007 ATU MS Research Funds donations to the National MS Society in Washington, DC, and the Samuel Lunenfeld Research Institute at Mount Sinai Hospital in Toronto, ON.

From left, International President Warren S. George presents the latest check donating this year’s contribution to the work of the Multiple Sclerosis Society to National MS Chapter President J. Christopher Broullire, and Research & Clinical Programs Vice President Dr. John Richert at the MS Society’s National Capital Chapter in Washington, DC. The presentation was made at the Society’s “research luncheon” outlining the progress made in the fight against the disease.
“We are incredibly fortunate to have partners like ATU in the fight against MS and are grateful for this year’s landmark tournament contribution to support MS research through the Promise: 2010 initiative,” stated MS Society National Capital Chapter Director of Development Kate Shifflett about the contribution.
In Canada
In Canada, Local 113-Toronto, ON, has been very active in raising money for the ATU MS Research Funds. Canadian contributions have gone to advance the MS research of Dr. John Roder at the Samuel Lunenfeld Research Institute of Mount Sinai Hospital.

Members of Local 113 are seen here making the Canadian MS donation. From left, are Brian Wicks, Rocco Signorile, Jim Boyle (in back), Financial Secretary Les Moore, Stan Rossell (in back), and Dr. Roder.
Mount Sinai Development Associate for Events Keiko Okutsu told International President George, “Mount Sinai Hospital is very grateful that the ATU has been a strong supporter of the research conducted at our renowned Samuel Lunenfeld Research Instititute. As in previous years, your donation will be directed to Dr. John Roder’s research in the area of multiple sclerosis and other neurological diseases.
“In the past year,” she continued, “Dr. Roder’s research focused around discovering the mechanism underlying neurological diseases… They have made great strides in understanding the multiple sclerosis gene in recent years and they are confident that there will be a cure for MS.” |
|
|
|
|
|